Why Is NGS Testing Now The First Step In Every Cancer Diagnosis In 2026
The "wait and see" approach to cancer treatment has been replaced by "Sequence and Strike" in 2026. Next-Generation Sequencing (NGS) of tumors is no longer a luxury for advanced cases; it is now the standard of care for every new diagnosis. By mapping the "Genetic Fingerprint" of a tumor, oncologists can identify the exact mutations driving the growth and select a "Targeted Therapy" that has the highest chance of success, often avoiding the "blanket" damage of traditional chemotherapy.
1 View